catalposide has been researched along with Hypertriglyceridemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, XH; Hoang, MH; Hwang, BY; Jia, Y; Jun, HJ; Lee, DH; Lee, HJ; Lee, JH; Lee, SJ | 1 |
1 other study(ies) available for catalposide and Hypertriglyceridemia
| Article | Year |
|---|---|
Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α.
Topics: Fatty Acids; Fluorescence Resonance Energy Transfer; Genes, Reporter; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Hypertriglyceridemia; Ligands; Lipid Metabolism; Lipids; PPAR alpha | 2012 |